![](https://ml.globenewswire.com/media/4dece45b-6a7e-4ce0-878c-63d3654a7474/small/kannalife-logo-png.png)
Kannalife Secures Funding of $1.49 Million from The Michael J. Fox Foundation for Parkinson’s Research
Funding of $1.49 million USD to support the development of KLS-13019 targeting neuroinflammation and mitochondrial dysfunction Kannalife has developed a new class of orally bioavailable drugs to address neurodegenerative and inflammatory diseases by …